AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $92,000 | -33.8% | 8,097 | -6.4% | 0.01% | -25.0% |
| Q2 2021 | $139,000 | -14.7% | 8,651 | -5.3% | 0.02% | -15.8% |
| Q1 2021 | $163,000 | +26.4% | 9,132 | -4.1% | 0.02% | +26.7% |
| Q4 2020 | $129,000 | +0.8% | 9,526 | -7.6% | 0.02% | 0.0% |
| Q3 2020 | $128,000 | -16.9% | 10,311 | -1.4% | 0.02% | -21.1% |
| Q2 2020 | $154,000 | +40.0% | 10,456 | +28.7% | 0.02% | +18.8% |
| Q1 2020 | $110,000 | -34.1% | 8,124 | +17.7% | 0.02% | -15.8% |
| Q4 2019 | $167,000 | +94.2% | 6,902 | +53.7% | 0.02% | +111.1% |
| Q3 2019 | $86,000 | -35.8% | 4,490 | -1.3% | 0.01% | -35.7% |
| Q2 2019 | $134,000 | -13.0% | 4,547 | +6.6% | 0.01% | -62.2% |
| Q4 2018 | $154,000 | -73.2% | 4,267 | -54.2% | 0.04% | -67.3% |
| Q3 2018 | $574,000 | -6.2% | 9,322 | +3.0% | 0.11% | -7.4% |
| Q2 2018 | $612,000 | +54.2% | 9,054 | +23.7% | 0.12% | +47.0% |
| Q1 2018 | $397,000 | -2.2% | 7,317 | +7.8% | 0.08% | +5.1% |
| Q4 2017 | $406,000 | +39.5% | 6,787 | +13.2% | 0.08% | +49.1% |
| Q3 2017 | $291,000 | +0.3% | 5,995 | +8.6% | 0.05% | +1.9% |
| Q2 2017 | $290,000 | -9.1% | 5,521 | -21.5% | 0.05% | +8.3% |
| Q1 2017 | $319,000 | +55.6% | 7,031 | +29.9% | 0.05% | +50.0% |
| Q4 2016 | $205,000 | +27.3% | 5,411 | +26.7% | 0.03% | +52.4% |
| Q3 2016 | $161,000 | – | 4,271 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|